EUVIMEDEUVIMED entdecken
Crossref

Metabolic Profiles and insulin therapy requirements among pregnant women with Gestational Diabetes mellitus and Type 2 Diabetes across self-identified Race/ethnic groups in Brooklyn NY, USA.

Shailini Singh, Daniel Martingano, Dimitrios S. Mastrogiannis, Antonia Olodipo, Jacklyn Tse, Supriya D Mahajan

American Journal of Perinatology · 19.11.2026

DOI: 10.1055/a-3008-4657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 19.11.2026. Verfasst von Shailini Singh und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Gestational diabetes mellitus (GDM) and type 2 diabetes (T2 DM) presents varying metabolic patterns across populations, yet the extent to which these differences appear at diagnosis remains unclear. This study examines whether baseline metabolic profiles differ among pregnant women from diverse racial and ethnic backgrounds. Our objective was to determine whether these metabolic differences may influence diabetes management during pregnancy. Study Design: We conducted a two‑year retrospective study of 200 insulin‑naïve women at NYU Langone hospital at Brooklyn, NY, diagnosed with GDM and or T2DM in the third trimester. The diagnostic criteria were standard two‑step testing , 50‑g glucose challenge (1Hr. GCT, cut off 135mg./DL) followed by a 100‑g Oral glucose tolerance test (OGTT). Baseline fasting labs included glucose, C‑peptide, and lipid profiles, with insulin sensitivity estimated using IS‑HOMA (C‑peptide). Management followed standardized diet, exercise, Metformin when appropriate, and weight‑based basal–bolus insulin titrated to fasting glucose levels 85–90 mg/dL and 2‑hour postprandial 115–120 mg/dL.

Results

Significant race/ethnicity‑specific metabolic phenotype differences emerged. Hispanic-Latina women and American born Black women had higher BMI, higher fasting C‑peptide, and lower insulin sensitivity, whereas Asian (Southeast and East Indian) and Caribbean/Haitian Black women showed lower C‑peptide but higher insulin sensitivity. Lipid patterns also varied. There was no statistically significant difference in birthweight across groups.

Conclusion

In this cohort, we observed distinct metabolic profiles across racial and ethnic groups at the time of GDM or T2DM diagnosis in pregnancy. These differences, particularly in insulin sensitivity, C‑peptide levels, and BMI, suggest that metabolic phenotype varies meaningfully by race and ethnicity. Incorporating these patterns into clinical decision‑making may help refine diabetes management strategies and support more equitable perinatal outcomes.

Zitieren

APA

Singh, S., Martingano, D., Mastrogiannis, D. S., Olodipo, A., Tse, J., & Mahajan, S. D. (2026). Metabolic Profiles and insulin therapy requirements among pregnant women with Gestational Diabetes mellitus and Type 2 Diabetes across self-identified Race/ethnic groups in Brooklyn NY, USA. American Journal of Perinatology. https://doi.org/10.1055/a-3008-4657

Vancouver

Singh S, Martingano D, Mastrogiannis DS, Olodipo A, Tse J, Mahajan SD. Metabolic Profiles and insulin therapy requirements among pregnant women with Gestational Diabetes mellitus and Type 2 Diabetes across self-identified Race/ethnic groups in Brooklyn NY, USA. American Journal of Perinatology. 2026. doi:10.1055/a-3008-4657

BibTeX
@article{Singh2026,
  author = {Singh, Shailini and Martingano, Daniel and Mastrogiannis, Dimitrios S. and Olodipo, Antonia and Tse, Jacklyn and Mahajan, Supriya D},
  title = {Metabolic Profiles and insulin therapy requirements among pregnant women with Gestational Diabetes mellitus and Type 2 Diabetes across self-identified Race/ethnic groups in Brooklyn NY, USA},
  journal = {American Journal of Perinatology},
  year = {2026},
  doi = {10.1055/a-3008-4657}
}
Kostenlos starten →